Blogbeiträge | Gen Re

Unsere Perspektive

The U.S. Critical Illness Market Remains Strong

Von Kayla Rooney |December 11, 2020|English

The results from our latest annual U.S. Critical Illness Insurance Market Survey are worth a look as favorable trends continue. 46 companies participated in this year’s survey, with the results representing 81 products that are currently in the...
Lesen Sie mehr
MINOCA - A New Type of Myocardial Infarction?

Von Dr. Sandra Mitic |September 03, 2020|English | Français

A new syndrome of myocardial infarction (MI) has been defined in the clinical context over the past few years - myocardial infarction with non-obstructive coronary arteries (MINOCA). Several large, international acute myocardial infarction (AMI) studies...
Lesen Sie mehr
Changes in Cancer Classification - How Do They Impact Critical Illness Insurance?

Von Tim Eppert |July 14, 2020|English | Français

What is a cancer - and what is not? While the answer to this question is obvious in many cases, it is not always straightforward. A disease is deemed as malignant or cancerous when there is an uncontrolled growth of cells that is invasive, i.e., the...
Lesen Sie mehr
World Cancer Day - Celebrating a Decline in U.S. Cancer Mortality

Von Jean-Marc Fix |February 04, 2020|English

When the Cancer Statistics, 2020 report was released a few weeks ago, the press rightfully basked in the great news: In the U.S. there were 2.9 million fewer cancer deaths than there would have been if the historically increasing cancer rates had remained...
Lesen Sie mehr
When Is a Heart Attack a Heart Attack?

Von Dr. John O'Brien |November 05, 2019|English

Right up until the 1960s no specific treatment for heart attack existed; patients were simply advised to go home and rest in bed. Today, although our understanding and treatment of what’s technically called myocardial infarction (MI) has come...
Lesen Sie mehr
Chronic Myeloid Leukaemia - From Fatal to Chronic Disease

Von Dr. John O'Brien |October 16, 2019|English

Major advances in the treatment of chronic myeloid leukaemia (CML) have produced a welcome improvement in its prognosis. CML used to be a universally fatal condition; now, for some patients, it can be considered a chronic illness with little impact...
Lesen Sie mehr